Ensysce Biosciences (ENSCW) Profit After Tax (2018 - 2025)
Ensysce Biosciences (ENSCW) reported Profit After Tax of -$3.7 million for Q3 2025, down 663.51% year-over-year from $661769.0 in Q3 2024, and down 115.12% quarter-over-quarter from -$1.7 million in Q2 2025.
Ensysce Biosciences (ENSCW) Profit After Tax (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 8 years of Profit After Tax data on file, last reported at -$3.7 million in Q3 2025.
- Profit After Tax for Q3 2025 came in at -$3.7 million, down 663.51% year-over-year; the trailing twelve-month figure through Sep 2025 was -$11.0 million (down 38.42% YoY), and the FY2024 annual result was -$8.0 million, up 24.84% from the prior year.
- Profit After Tax eased to -$3.7 million in Q3 2025 per ENSCW's latest filing, from -$1.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at $661769.0 in Q3 2024 and troughed at -$17.2 million in Q3 2021.
- A 5-year average of -$4.2 million and a median of -$2.7 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2021 and 2024: Profit After Tax sank 54828.05% in 2021, then soared 124.59% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$10.0 million in 2021, then jumped by 45.42% to -$5.5 million in 2022, then jumped by 36.03% to -$3.5 million in 2023, then decreased by 1.71% to -$3.6 million in 2024, then retreated by 4.62% to -$3.7 million in 2025.
- Business Quant data shows ENSCW's Profit After Tax at -$3.7 million in Q3 2025, -$1.7 million in Q2 2025, and -$1.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.73 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -1.95 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | 661,769.00 |
| Jun 30, 2024 | -1.97 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Dec 31, 2023 | -3.50 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -2.19 Mn |
| Dec 31, 2022 | -5.48 Mn |
| Sep 30, 2022 | -9.86 Mn |
| Jun 30, 2022 | -7.92 Mn |
| Mar 31, 2022 | -950,925.00 |
| Dec 31, 2021 | -10.04 Mn |
| Sep 30, 2021 | -17.20 Mn |
| Jun 30, 2021 | -957,611.00 |
| Mar 31, 2021 | -911,692.00 |
| Dec 31, 2020 | 18,340.00 |